North America PCR Multiplex Assays Market By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Countries (U.S., Canada, Mexico) – Industry Trends & Forecast to 2026
Multiplex assays are the new technology which is incorporated with the capability to run more than one target sequence in a single step, the evolution of the PCR multiplex assays in terms of smart features with voice command, facial authentication and radio-frequency identification (RFID) features changes from an manual instrument to an automated PCR multiplexes systems in the year 2016 to 2018.
Multiplex assay can amplify more than one target sequence with the help of multiple primer pairs in reaction mixtures. The PCR technique is a time saving with significant less efforts in the laboratory experiments, which is a convenient and rapid screening assay for clinical and research laboratories. The PCR multiplex assay manufactures to expand their business for the development of services. For instance In June 2018, QIAGEN announced the launch of QIAseq 16S Panels and UCP Multiplex PCR kit which enables in the profiling of complex microbiome samples. The new products reduce the profiling bias and a kit is featured with the nucleic acid-depleted reagents which are tested for the fungal and bacterial DNA contamination. QIAseq 16S Panels enhances robust profiling with the flexibility and interrogates of fungal ITS regions and bacterial 16S variable regions on Illumina platforms. The product is designed with unbiased microbiome profiling and helping scientists to avoid external biased obstacle. The introduction of product helps clinicians in microbial profiling and expanded the advanced product portfolio of the company.